Back to NBIX
STATE STREET CORP NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
12
Latest value
$739.1M
Q2 2026
Peak value
$739.1M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $535.4M |
| Q1 2024 | $550.3M |
| Q2 2024 | $634.4M |
| Q3 2024 | $593.2M |
| Q4 2024 | $667.7M |
| Q1 2025 | $537.8M |
| Q2 2025 | $561.6M |
| Q3 2025 | $610.2M |
| Q4 2025 | $601.7M |
| Q1 2026 | $573.7M |
| Q2 2026 | $739.1M |
| Q2 2026 | $739.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $739.1M | 4.39M | — | — |
| Q2 2026 | $739.1M | 4.39M | — | — |
| Q1 2026 | $573.7M | 4.35M | — | — |
| Q4 2025 | $601.7M | 4.24M | — | — |
| Q3 2025 | $610.2M | 4.35M | — | — |
| Q2 2025 | $561.6M | 4.47M | — | — |
| Q1 2025 | $537.8M | 4.86M | — | — |
| Q4 2024 | $667.7M | 4.89M | — | — |
| Q3 2024 | $593.2M | 5.15M | — | — |
| Q2 2024 | $634.4M | 4.61M | — | — |
| Q1 2024 | $550.3M | 3.99M | — | — |
| Q4 2023 | $535.4M | 4.06M | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M